Eleonora Bongiovanni
7PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 13, 2025
The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies.Valentina Pala, Francois Rosset, Luca Mastorino
|Sep 22, 2025
Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence.Francois Rosset, Nadia Sciamarrelli, Luca Mastorino
|Jul 23, 2025
Drug survival, effectiveness and safety of risankizumab for moderate-to-severe psoriasis for up to 4 years.Luca Mastorino, Paolo Dapavo, Michela Ortoncelli
|Jun 11, 2025
Dose modulation strategies in patients with psoriasis: real-world comparison between secukinumab and brodalumab for up to 1 year after dose spacing.Luca Mastorino, Paolo Dapavo, Michela Ortoncelli
|Mar 21, 2025
Safety Profile of Baricitinib in Patients With Severe Alopecia Areata: A Prospective Study.Isotta Giunipero di Corteranzo, Eleonora Bongiovanni, Stephano Cedirian
|Sep 14, 2024
Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma.Gabriele Roccuzzo, Paolo Fava, Chiara Astrua
Pageof 2
Frequent Collaborators
3 joint publications
Simone Ribero
3 joint publications
Luca Mastorino
2 joint publications
Umberto Santaniello
2 joint publications
Francois Rosset
2 joint publications
Valentina Pala
2 joint publications
Orsola Crespi
1 joint publications
Gabriele Roccuzzo
1 joint publications
Paolo Fava
1 joint publications
Isotta Giunipero di Corteranzo
1 joint publications
Stephano Cedirian
